Peer Review History

Original SubmissionApril 29, 2021
Decision Letter - Arne Elofsson, Editor, Damiano Piovesan, Editor

Dear Dr Reinhardt,

Thank you very much for submitting your manuscript "Targeted modulation of protein liquid-liquid phase separation by evolution of amino-acid sequence" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Damiano Piovesan

Guest Editor

PLOS Computational Biology

Arne Elofsson

Deputy Editor

PLOS Computational Biology

***********************

A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately:

[LINK]

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors presented a high-quality and original piece of work aiming to efficiently modulate the liquid-liquid phase separation of proteins by iteratively introducing changes in the protein sequence by a genetic algorithm. The method relies on coarse-graining the protein structure and a simple but effective fitness function, and is able to estimate the phase diagram of the protein. The build-up of the manuscript is logical, the language is clear, the results and methods are detailed and depicted sufficiently. I very much appreciated the use of 3 different protein systems, the comparison of different scoring models and the efforts for the validation. With the incorporation of the mostly minor points listed below, I highly recommend the publication of the article.

Major point:

1. It would be very insightful to compare the genetic algorithm with a dummy algorithm that introduces random mutations (using the same number of rounds or iteration cycles).

Minor points:

1. Fig 2B, Fig 4B, Fig 5B seem to use different colours from the colour scales, as white colour does not appear on the blue-brown-orange and blue-purple-red colour scales, only on the figures. Please show the appropriate colour scales.

2. Statistical significance is unclear in the following sentence: "This pair correlation function exhibits a more pronounced nearest-neighbour maximum, indicating a greater degree of local structure and an increase in the number of nearest-neighbour beads compared to the WT..."
 Could you please add the appropriate statistics?

3. In Fig 3A the colour scale of hydrophobicity should match with that of Fig 2B [0,1] in order to avoid interpretation bias.

4. Please add the correlation coefficient to the following sentences of the main text: "Fig. 3(A) shows the results of a glycine scan in sequential chunks of 6 amino acids, projected onto the chunk-averaged hydrophobicities of the WT protein. The curves anti-correlate for most of the sequence…"
 & "Our comparison indicates that there is a good positive correlation between the predictions of the sequence-dependent coarse-grained models we have used and the experimental results…"

5. When simulating two-component systems, the RNA:protein stoichiometry was chosen to be 1:7, which I believe is not physiologically relevant. What about choosing a more relevant stoichiometry for an additional GA run?

6. Please add the correlation coefficient for the simulated data using KH and cation-pi models. This would quantify the disagreement between the two models.

7.i. The word amino acid is written as 'amino acids' or 'amino-acids' inconsistently. Please remove/add the hyphens.

7.ii. The same issue was found for 'genetic algorithm' vs 'genetic-algorithm'.

8. I’m very happy to see that the data will be made publicly available. However, it is a pity it is unavailable under the review. Please make sure that the analysis scripts to reproduce the evaluation of the simulations results are also archived with the simulation files.

Reviewer #2: The manuscript by Lichtinger and colleagues presents an interesting computational approach for investigating the effect of sequence modifications in Intrinsically Disordered Regions (IDRs) in three well-studied proteins (FUS, hnRNPA1, LAF1) known to undergo homotypic liquid-liquid phase separation (LLPS) and their LLPS potential. In particular, they propose a simple to compute fitness function to guide a Genetic Algorithm (GA) coupled with coarse-grained molecular dynamics (MD) simulations towards evolving sequences that have desired (increased or decreased) LLPS tendency compared to the wild type.

The work presented is novel, and aims to tackle an important and timely problem. Overall, the manuscript is well written, starting with a brief -yet informative- introduction on the current knowledge in the current knowledge of the driving forces behind LLPS. Then the authors describe a computationally tractable approach to tackle the problem of training a GA to shift the phase behavior of a starting (WT) sequence to a local optimum. This becomes feasible by introducing the difference in composition densities between the protein-rich and protein-poor phases in an appropriately designed coarse-grained MD simulation of the protein region in question. The authors present results on three IDRs know to drive LLPS in vitro and in vivo, and validate their results against more detailed, all-atom MD simulations. The results presented herein do not identify a single driving force for LLPS but provides some useful insights on parameters other than charge, hydrophobicity and their patterning along sequences that should also be considered when rationally designing mutations for promoting/inhibiting LLPS. In addition, examples where RNAs are introduced in the FUS/hnRNPA1 simulations are presented, aiming to demonstrate the potential of the proposed approach to handle more complex systems.

Below are some points that I believe warrant some attention by the authors. Page numbers refer to the page number of the final PDF file produced in the Editorial Manager system and not the page numbers inserted by the word processing tool.

+ Specific comments

- The manuscript is accompanied by detailed supplementary material. Even though some methodological details (especially those referring to existing methods) are safe to reside in the supplement, I would prefer a large portion of this material to be transferred to the main text (e.g. S4-S9, S12).

- Regarding the results presented in Fig 2A, it is apparent that when FUS-WT is evolved to either high or low Tc, Ser residues seem to decrease (same holds for Gln and Thr even though these changes seem weaker). Could this observation be explained by some positional preferences? Please discuss.

In addition, in Fig 2B it is mentioned that "Trends in hydrophobicity and are largely correlated". It is unclear though if this correlation is somehow quantified. In addition, there exist several clusters of successive residues that seem to not have undergone mutation: doe these correspond to cases where mutations in these positions were not explored by the GA or that such mutants were rejected during the simulation? Are there any particular features of the WT sequences in these stretches? Please discuss.

- Regarding the Glycine-scans presented (pg. 12), a chunk size of 6 AAs was chosen. However, the results shown in Fig 3B are interpreted by the authors that segments of 2-3 successive AAs are crucial in driving LLPS in FUS. Would it be more meaningful if the Glycine-scans were performed with a chunk size of 2 or 3 AAs?

Another question related to Fig 3B: when chunks a shuffled it is not necessary that all residue types are changed - is this taken into account?

- It is unclear what the two evolved variants of LAF1 mentioned in pg. 16 refers to. Please explain how these variants were selected and what is their relevance.

- Under section (V) the authors interpret the results shown in Fig 6A in a descriptive way. They mention wrt FUS that "the creation of more lysine (K) residues is largely offset by creating fewer arginine (R) residues, which have the same charge". However, simple inspection of Fig 6A indicates that net positive charge (especially if His is also taken into account) seems to clearly increase in the presence of RNA (while negative charge decreases). With minor only changes involving negatively charged residues I suspect that there might be some misinterpretation here (or I have missed some crucial detail).

+ Minor comments and typos

- pg. 8. When mentioning "sufficient number of copies": How is this number selected?

- pg. 9. "[(2)]" should better read "[(Equation 2)]. The same also holds for the legend of Fig 1 (B).

- pg. 16. It is unclear to me (a) why the GA progression is slower with this system and (b) why are finite-size effects are more pronounced? The LAF1 IDR is approx the same length compared to the respective FUS domain, so I suspect it is not a matter of length. Could you please elaborate?

- pg. 16. "... the amino acids early in the sequence ...", does it refer to the most N-terminal residues? Please clarify.

- pg. 19. Since the preprint by Bremer et al [ref. 23] is quite new and most readers may not be very familiar with the naming convention of hnRNPA1 analogues (+7R and +7F−7Y), please consider briefly describing them in the text or supplement for clarity.

- pg. 21. "encourage or inhibit" might better read as "promote or inhibit".

- pg. 22. The symbol P refers to denote either the mutation rate (point 1) or the set of parents (point 2) which could be misleading.

- pg. 31. Under S1, in the mutant hnRNPA1 sequences it could be useful to highlight mutations wrt the WT.

Reviewer #3: The paper entitled “Targeted modulation of protein liquid-liquid phase separation by evolution of amino-acid sequence” by Lichtinger et al. addresses an important and challenge topic in the field of LLPS, aiming to understand how single point amino acid variations affect the driving forces in LLPS, modulating it. They followed a novel computational methodology by combining genetic algorithms and sequence-dependent coarse-grained protein models, to evolve amino-acid sequences of phase separating IDPs. The authors performed a deep analysis with a very precise and rigorous methodology on the different sequence properties as hydrophobicity and residue charge in the wild type and the evolved sequences of PLD of FUS, hnRNA and LAF1, well-studied proteins in the LLPS field. Their observations suggest that not all proteins that phase separate are governed by the same the driving forces. Moreover, authors validate their findings seen by fitting the predictions against experimental phase diagrams for a set of sequences of hnRNA1, and by using a more realistic and accurate ABSINTH model.

Authors present a novel and efficient way to evolve naturally occurring phase-separating protein sequences, however my only concern regards to generalization of this method to other proteins and its robustness. Since only few protein sequences have been used in this work, I suggest extending the discussion about how this method could be applied at large-scale on the current LLPS databases (e.g., PhasePro, PhaSepDB, etc). This may allow to identify group of proteins that exhibit LLPS and are governed by similar driving forces. After addressing this minor comment, I recommend this work to be published in PLOS Computational Biology.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: No: The authors mention that the data will be made available upon acceptance. Therefore, I cannot comment on whether all required material will be provided.

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Vasilis J Promponas

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Revision 1

Attachments
Attachment
Submitted filename: coverletter-revision-plos.pdf
Decision Letter - Arne Elofsson, Editor, Damiano Piovesan, Editor

Dear Dr Reinhardt,

We are pleased to inform you that your manuscript 'Targeted modulation of protein liquid-liquid phase separation by evolution of amino-acid sequence' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Damiano Piovesan

Guest Editor

PLOS Computational Biology

Arne Elofsson

Deputy Editor

PLOS Computational Biology

***********************************************************

Formally Accepted
Acceptance Letter - Arne Elofsson, Editor, Damiano Piovesan, Editor

PCOMPBIOL-D-21-00779R1

Targeted modulation of protein liquid–liquid phase separation by evolution of amino-acid sequence

Dear Dr Reinhardt,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .